Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
A 16.54 4.03% 0.64
MRNS closed up 4.03 percent on Friday, March 5, 2021, on 1.44 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Mar 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MRNS trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 4.03%
Upper Bollinger Band Walk Strength 4.03%
Overbought Stochastic Strength 4.03%
Upper Bollinger Band Touch Strength 4.03%
New 52 Week Closing High Bullish 0.61%
Pocket Pivot Bullish Swing Setup 0.61%
Upper Bollinger Band Walk Strength 0.61%
Older End-of-Day Signals for MRNS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Neuroscience Alcohols Ketones Seizure Seizures Sedatives Fragile X Syndrome Pregnanes Neurosteroids

Is MRNS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.14
52 Week Low 4.16
Average Volume 335,515
200-Day Moving Average 11.77
50-Day Moving Average 13.65
20-Day Moving Average 15.10
10-Day Moving Average 15.47
Average True Range 0.93
ADX 30.42
+DI 24.31
-DI 13.67
Chandelier Exit (Long, 3 ATRs ) 14.07
Chandelier Exit (Short, 3 ATRs ) 15.91
Upper Bollinger Band 16.64
Lower Bollinger Band 13.56
Percent B (%b) 0.97
BandWidth 20.38
MACD Line 0.70
MACD Signal Line 0.58
MACD Histogram 0.1247
Fundamentals Value
Market Cap 506.03 Million
Num Shares 30.6 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -16.84
Price-to-Sales 1962.98
Price-to-Book 5.65
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.64
Resistance 3 (R3) 18.42 17.51 18.29
Resistance 2 (R2) 17.51 16.97 17.62 18.17
Resistance 1 (R1) 17.02 16.64 17.27 17.24 18.06
Pivot Point 16.11 16.11 16.23 16.22 16.11
Support 1 (S1) 15.62 15.57 15.87 15.84 15.02
Support 2 (S2) 14.71 15.24 14.82 14.91
Support 3 (S3) 14.22 14.71 14.79
Support 4 (S4) 14.44